These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9371337

  • 1. Human immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogs.
    Nillroth U, Vrang L, Markgren PO, Hultén J, Hallberg A, Danielson UH.
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2383-8. PubMed ID: 9371337
    [Abstract] [Full Text] [Related]

  • 2. Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors.
    Ala PJ, Huston EE, Klabe RM, McCabe DD, Duke JL, Rizzo CJ, Korant BD, DeLoskey RJ, Lam PY, Hodge CN, Chang CH.
    Biochemistry; 1997 Feb 18; 36(7):1573-80. PubMed ID: 9048541
    [Abstract] [Full Text] [Related]

  • 3. Systematic molecular dynamics, MM-PBSA, and ab initio approaches to the saquinavir resistance mechanism in HIV-1 PR due to 11 double and multiple mutations.
    Tzoupis H, Leonis G, Avramopoulos A, Mavromoustakos T, Papadopoulos MG.
    J Phys Chem B; 2014 Aug 14; 118(32):9538-52. PubMed ID: 25036111
    [Abstract] [Full Text] [Related]

  • 4. Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.
    Majerová-Uhlíková T, Dantuma NP, Lindsten K, Masucci MG, Konvalinka J.
    J Clin Virol; 2006 May 14; 36(1):50-9. PubMed ID: 16527535
    [Abstract] [Full Text] [Related]

  • 5. Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance.
    Hong L, Zhang XC, Hartsuck JA, Tang J.
    Protein Sci; 2000 Oct 14; 9(10):1898-904. PubMed ID: 11106162
    [Abstract] [Full Text] [Related]

  • 6. Analysis of resistance to human immunodeficiency virus type 1 protease inhibitors by using matched bacterial expression and proviral infection vectors.
    Maschera B, Furfine E, Blair ED.
    J Virol; 1995 Sep 14; 69(9):5431-6. PubMed ID: 7636988
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elucidation of HIV-1 protease resistance by characterization of interaction kinetics between inhibitors and enzyme variants.
    Shuman CF, Markgren PO, Hämäläinen M, Danielson UH.
    Antiviral Res; 2003 May 14; 58(3):235-42. PubMed ID: 12767471
    [Abstract] [Full Text] [Related]

  • 11. Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy.
    Kantor R, Fessel WJ, Zolopa AR, Israelski D, Shulman N, Montoya JG, Harbour M, Schapiro JM, Shafer RW.
    Antimicrob Agents Chemother; 2002 Apr 14; 46(4):1086-92. PubMed ID: 11897594
    [Abstract] [Full Text] [Related]

  • 12. Structural and kinetic analysis of drug resistant mutants of HIV-1 protease.
    Mahalingam B, Louis JM, Reed CC, Adomat JM, Krouse J, Wang YF, Harrison RW, Weber IT.
    Eur J Biochem; 1999 Jul 14; 263(1):238-45. PubMed ID: 10429209
    [Abstract] [Full Text] [Related]

  • 13. Counteracting HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with XV638 and SD146, cyclic urea amides with broad specificities.
    Ala PJ, Huston EE, Klabe RM, Jadhav PK, Lam PY, Chang CH.
    Biochemistry; 1998 Oct 27; 37(43):15042-9. PubMed ID: 9790666
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multidrug resistance to HIV-1 protease inhibition requires cooperative coupling between distal mutations.
    Ohtaka H, Schön A, Freire E.
    Biochemistry; 2003 Nov 25; 42(46):13659-66. PubMed ID: 14622012
    [Abstract] [Full Text] [Related]

  • 16. Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450.
    Hodge CN, Aldrich PE, Bacheler LT, Chang CH, Eyermann CJ, Garber S, Grubb M, Jackson DA, Jadhav PK, Korant B, Lam PY, Maurin MB, Meek JL, Otto MJ, Rayner MM, Reid C, Sharpe TR, Shum L, Winslow DL, Erickson-Viitanen S.
    Chem Biol; 1996 Apr 25; 3(4):301-14. PubMed ID: 8807858
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection.
    Vasudevachari MB, Zhang YM, Imamichi H, Imamichi T, Falloon J, Salzman NP.
    Antimicrob Agents Chemother; 1996 Nov 25; 40(11):2535-41. PubMed ID: 8913459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.